Erratum: Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells (Gene Therapy (2006) vol. 13 (1714-1723) 10.1038/sj.gt.3302808);Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells

Gene Therapy

Volumn 13, Issue 24, 2006, Pages 1714-1723

  Yang, R ^a,b   Yang, X ^b   Zhang, Z ^b   Zhang, Y ^b   Wang, S ^b   Cai, Z ^c   Jia, Y ^d   Ma, Y ^b   Zheng, C ^c   Lu, Y ^b   Roden, R ^a   Chen, Y ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NANKAI UNIVERSITY   (China)

^c Tianjin Chest Hospital   (China)

^d China Civil Aviation University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,6 HEXANEDIAMINE; B7 ANTIGEN; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; LEWIS CARCINOMA; MOUSE; NANOTUBE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR IMMUNITY;

EID: 33845198629     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302962     Document Type: Erratum

References (31)

1. Sontheimer EJ. Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol 2005; 6: 127-138.
2. Agrawal S, Kandimalla ER. Role of Toll-like receptors in antisense and siRNA. Nat Biotechnol 2004; 22: 1533-1537.
3. Paroo Z, Corey DR. Challenges for RNAi in vivo. Trends Biotechnol 2004; 22: 390-394.
4. Manoharan M. RNA interference and chemically modified small interfering RNAs. Curr Opin Chem Biol 2004; 8: 570-579.
5. Huang WJ, Tayor S, Fu KF, Lin Y, Zhang DH, Hanks TW et al. Attaching proteins to carbon nanotubes via diimide-activated amidation. Nano Lett 2002; 2: 311-314.
6. Pantarotto D, Briand J, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun 2004; 1: 16-17.
7. Williams KA, Veenhuizen PT, De la Torre BG, Eritja R, Dekker C. Nanotechnology: Carbon nanotubes with DNA recognition. Nature 2002; 420: 761.
8. Nguyen C, Delzeit L, Cassell AM, Li J, Han J, Meyyappan M. Preparation of nucleic acid functionalized carbon nanotube Arrays. Nano Lett 2002; 2: 1079-1081.
9. Pompeo F, Resasco D. Water solubilization of single-walled carbon nanotubes by functionalization with glucosarnine. Nano Lett 2002; 2: 369-373.
10. Sano M, Kamino A, Okamura J, Shinkai S. Self-organization of PEO-graft-single-walled carbon nanotubes in solutions and Langmuir-Blodgett films. Langmuir 2001; 17: 5125-5128.
11. Kam NW, Liu Z, Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005; 127: 12492-12493.
12. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2: 151-161.
13. Akbari O, Umetsu DT. Role of regulatory dendritic cells in allergy and asthma. Curr Allergy Asthma Rep 2005; 5: 56-61.
14. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 2003; 4: 1169-1176.
15. Shen L, Evel-Kabler K, Strube R, Chen SY. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat Biotechnol 2004; 22: 1546-1553.
16. Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: Toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc 2005; 127: 4388-4396.
17. Yang R, Murillo FM, Lin KY, Yutzy WHth, Uematsu S, Takeda K et al. Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations. J Immunol 2004; 173: 2624-2631.
18. Hill JA, Ichim TE, Kusznieruk KP, Li M, Huang X, Yan X et al. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol 2003; 171: 691-696.
19. Au WY, Hung KN, Wan TS, Ma E. Side effects related to cancer treatment: CASE 3. Primary cerebral lymphoma after radiotherapy for recurrent meningioma. J Clin Oncol 2005; 23: 8535-8536.
20. Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 2006; 16: 53-65.
21. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346-358.
22. Sioud M. On the delivery of small interfering RNAs into mammalian cells. Expert Opin Drug Deliv 2005; 4: 639-651.
23. Kobayashi T, Yoshimura A. Keeping DCs awake by putting SOCS1 to sleep. Trends Immunol 2005; 26: 177-179.
24. Peng S, Kim TW, Lee JH, Yang M, He L, Hung CF et al. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum Gene Ther 2005; 16: 584-593.
25. Lv X, Du F, Ma YF, Wu Q, Chen YS. Synthesis of high quality single-walled carbon nanotubes at large scale by electric arc using metal compounds. Carbon 2005; 43: 2020-2022.
26. Hazani M, Naaman R, Hennrich F, Kappes M. Confocal fluorescence imaging of DNA-functionalized carbon nanotubes. Nano Lett 2003; 3: 153-155.
27. Far S, Kossanyi A, Verchere-Beaur C, Gresh N, Taillandier E, Perree-Fauvet M. Bis- and tris-DNA intercalating porphyrins designed to target the major groove: Synthesis of acridylbis-arginyl-porphyrins, molecular modelling of their DNA complexes, and experimental tests. Eur J Org Chem 2004; 8: 1781-1797.
28. Chen J, Hamon MA, Hu H, Chen Y, Rao AM, Eklund PC. Solution properties of single-walled carbon nanotubes. Science 1998; 282: 95-98.
29. Han G, Tamaki M, Hruby VJ. Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4 m). J Pept Res 2001; 58: 338-341.
30. Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol 2001; 166: 5398-5406.
31. Yang R, Murillo FM, Cui H, Blosser R, Uematsu S, Takeda K et al. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J Virol 2004; 78: 11152-11160.